• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

flu vaccine

An artists impression of influenza molecules The molecules are blue and have multicolored centers
Biotech

Pfizer details phase 3 data for mRNA flu vaccine

The potential new shot securing 34.5% greater effectiveness compared to Sanofi's Fluzone.
Darren Incorvaia Nov 20, 2025 11:25am
flu virus b cells influenza

Moderna flu vaccine beats approved competitor in fresh ph. 3 win

Jun 30, 2025 8:05am
cancel

Moderna withdraws FDA filing for flu/COVID combination vaccine

May 21, 2025 9:35am
The particles polygonal geometric art - Vaccine abstract vector illustration

HHS unveils $500M universal vaccine development initiative

May 1, 2025 2:55pm
flu virus b cells influenza

GSK's mRNA flu vaccine finally bests tricky B strains in phase 2

Sep 12, 2024 4:52am
pipeline pipes RD research

Sanofi will drop dwarfism drug as part of rare disease clear-out

Jul 25, 2024 7:58am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings